thumbnail img

The Differences Between the Vaccines Matter

News March 11, 2021 | CanadaOnlineHealth

Public-health officials are enthusiastic about the new, single-shot COVID-19 vaccine from Johnson & Johnson, despite its having a somewhat lower efficacy at preventing symptomatic illness than other available options. Although clinical-trial data peg that rate at 72 percent in the United States, compared with 94 and 95 percent for the Moderna and Pfizer-BioNTech vaccines, many experts say we shouldn’t fixate on those numbers.

READ THE FULL ARTICLE HERE

Recent Posts
Newsletter

Join our email list to receive our newsletter with special offers, exclusive discounts, and timely product information

We respect your email privacy.


Leave A Reply



Live Chat